Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Case of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome Responsive to IVIG
Neuromuscular and Clinical Neurophysiology (EMG)
P12 - Poster Session 12 (12:00 PM-1:00 PM)
1-009

Raise awareness about  pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

The pharyngeal-cervical-brachial variant of Guillain-Barré syndrome belongs to the clinical spectrum of the anti-GQ1b syndrome which also includes Miller-Fisher syndrome, acute ophthalmoparesis, and Bickerstaff brainstem encephalitis. This condition may result in severe disability. Several therapeutic approaches have been tried with variable success. We present a case that responded very well to IVIG.
Case report

This is a 48-year-old woman who presented with acute vertigo, unsteadiness, diplopia, ascending paresthesias and numbness that started in her hands. She had nasal voice and dysphagia.  She had upper respiratory infection one week before.

Examination was remarkable for right eye esotropia on primary gaze, right lateral and left lateral gaze palsy. No nystagmus or ptosis was seen. She elevated the palate minimally symmetrically. Power of neck flexion and extension, shoulder adduction, forward flexion, external and internal rotation, elbow flexion and extension was 4/5. The remaining motor strength was 5/5. Reflexes were 0 at biceps, brachioradialis, triceps bilaterally, 1 at patella bilaterally, and 2 at Achilles tendon bilaterally. Sensory exam was intact in the legs but there was light touch and pin prick gradient at the wrist. Gait was cautious and wide-based but Romberg testing was negative.

Brain MRI, lumbar puncture and blood tests were unremarkable except for positive IgG anti-GQ1b antibodies: 259 IV (normal 0-50 IV). Anti GM1 and anti-GD1b antibodies were negative. The nerve conduction studies demonstrated non-length dependent sensory neuronopathy. This presentation is suggestive of the pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

She received IVIG 2g/kg with recovery of weakness, voice and swallowing abnormalities within one week. Diplopia although improved, persists.

This case of pharyngeal-cervical-brachial variant of Guillain-Barré following respiratory infection with positive anti-GQ1b antibodies responded well to treatment. Early recognition and treatment may improve the outcome of this rare but potentially disabling condition.

Authors/Disclosures
Ryan C. Corn, DO (Stony Brook University Hospital, SUNY Stony Brook)
PRESENTER
Dr. Corn has nothing to disclose.
Philip Yeung, MD (Northwell Manhasset) Dr. Yeung has nothing to disclose.
Adrian Marchidann, MD (Kings County Hospital) Dr. Marchidann has stock in Eli Lilly. Dr. Marchidann has stock in Pfizer. Dr. Marchidann has stock in Merck. Dr. Marchidann has stock in Illumina. Dr. Marchidann has stock in Aeterna Zentaris. Dr. Marchidann has stock in Abbot. Dr. Marchidann has received publishing royalties from a publication relating to health care. Dr. Marchidann has received publishing royalties from a publication relating to health care.
Simona Treidler, MD (Stony Brook University) Dr. Treidler has nothing to disclose.